Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index, and 1 are not checked yet.

Microfluidic-Assisted Preparation of 5-Fluorouracil-Loaded PLGA Nanoparticles as a Potential System for Colorectal Cancer Therapy

Open access
Ghasemi Toudeshkchouei, Mahtab, Zahedi, Payam, Shavandi, Amin · 2020 · Materials

Abstract

This work aims at fabricating 5-fluorouracil (5-FU)-loaded poly (lactic-co-glycolic) acid nanoparticles (PLGA NPs) using a microfluidic (MF) technique, with potential for use in colorectal cancer therapy. In order to achieve 5-FU-loaded NPs with an average diameter of approximately 119 nm, the parameters of MF process with fork-shaped patterns were adjusted as follows: the ratio of polymer to drug solutions flow rates was equal to 10 and the solution concentrations of PLGA as carrier, 5-FU as anti-cancer drug and poly (vinyl alcohol) (PVA) as surfactant were 0.2 (% w/v), 0.01 (% w/v) and 0.15 (% w/v), respectively. In this way, a drug encapsulation efficiency of approximately 95% into the PLGA NPs was obtained, due to the formation of a hydrodynamic flow focusing phenomenon through the MF chip. A performance evaluation of the NP samples in terms of the drug release, cytotoxicity and cell death was carried out. Finally, by analyzing the results after induction of cell death and 4′, 6-diamidino-2-phenylin-dole (DAPI) staining, MF-fabricated NPs containing 5-FU [0.2 (% w/v) of PLGA] revealed the dead cell amounts of 10 and 1.5-fold higher than the control sample for Caco2 and SW-480, respectively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ma13071483

Cites

43 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic of microfluidic (MF) device setup.
Figure 1 Schematic of microfluidic (MF) device setup.CC BY · PubMed Central
Figure 2 Effect of flow rates ratio (Qpolymer/Qdrug) on the production of poly (lactic-co-glycolic) acid (PLGA) droplets: (A) 10, (B) 5, (C) 3.3 and (D) 2.5. To achieve these values, the drug flows in the middle channel were adjusted at 0.5 mL/h, 1 mL/h, 1.5 mL/h and 2 mL/h. Also, the polymer flow in the side channels was fixed at 5 mL/h.
Figure 2 Effect of flow rates ratio (Qpolymer/Qdrug) on the production of poly (lactic-co-glycolic) acid (PLGA) droplets: (A) 10, (B) 5, (C) 3.3 and (D) 2.5. To achieve these values, the drug flows in the middle channel were adjusted at 0.5 mL/h, 1 mL/h, 1.5 mL/h and 2 mL/h. Also, the polymer flow in the side channels was fixed at 5 mL/h.CC BY · PubMed Central
Figure 3 FE-SEM images of the nanoparticles (NPs) with different concentration ratios: (A1) 0.1% of PLGA at 6000×, (A2) 0.1% of PLGA at 30,000×, (A3) a size representation of 0.1% of PLGA NP at 40,000×, (B1) 0.2% of PLGA at 6000×, (B2) 0.2% of PLGA at 30,000×, (B3) a size representation of 0.2% of PLGA NP at 30,000×, (C1) 0.3% of PLGA at 6000×, (C2) 0.3% of PLGA at 30,000 X, (C3) a size representation of 0.3% of PLGA NP at 30,000×, (D1) 0.5% of PLGA at 6000×, (D2) 0.5% of PLGA at 30,000× and (D3) a size representation of 0.5% of PLGA NP at 60,000×.
Figure 3 FE-SEM images of the nanoparticles (NPs) with different concentration ratios: (A1) 0.1% of PLGA at 6000×, (A2) 0.1% of PLGA at 30,000×, (A3) a size representation of 0.1% of PLGA NP at 40,000×, (B1) 0.2% of PLGA at 6000×, (B2) 0.2% of PLGA at 30,000×, (B3) a size representation of 0.2% of PLGA NP at 30,000×, (C1) 0.3% of PLGA at 6000×, (C2) 0.3% of PLGA at 30,000 X, (C3) a size representation of 0.3% of PLGA NP at 30,000×, (D1) 0.5% of PLGA at 6000×, (D2) 0.5% of PLGA at 30,000× and (D3) a size representation of 0.5% of PLGA NP at 60,000×.CC BY · PubMed Central
Figure 4 NPs size and their size distribution curves based on dynamic light scattering (DLS) at different PLGA concentrations: (A) 0.1 (% w/v), (B) 0.2 (% w/v), (C) 0.3 (% w/v) and (D) 0.5 (% w/v). (The p-value for all data was less than 0.05).
Figure 4 NPs size and their size distribution curves based on dynamic light scattering (DLS) at different PLGA concentrations: (A) 0.1 (% w/v), (B) 0.2 (% w/v), (C) 0.3 (% w/v) and (D) 0.5 (% w/v). (The p-value for all data was less than 0.05).CC BY · PubMed Central
Figure 5 In vitro release profiles of neat 5-FU and PLGA NPs (0.2)/5-FU during 165 h.
Figure 5 In vitro release profiles of neat 5-FU and PLGA NPs (0.2)/5-FU during 165 h.CC BY · PubMed Central
Figure 6 MTT cytotoxicity assay results: Caco2 (A) 24 h, (B) 48 h and SW-480 (C) 24 h and (D) 48 h. Also, IC50 of 5-FU dosage in various concentrations through cell culture (E). [One star stands for p-value less than 0.05 and two stars stand for p-value more than 0.1].
Figure 6 MTT cytotoxicity assay results: Caco2 (A) 24 h, (B) 48 h and SW-480 (C) 24 h and (D) 48 h. Also, IC50 of 5-FU dosage in various concentrations through cell culture (E). [One star stands for p-value less than 0.05 and two stars stand for p-value more than 0.1].CC BY · PubMed Central
Figure 7 Flow cytometry results for Caco2 cell line: (A) control, (B) neat 5-FU and (C) PLGA NPs (0.2)/5-FU, besides for SW-480 cell line: (D) control, (E) neat 5-FU and (F) PLGA NPs (0.2)/5-FU.
Figure 7 Flow cytometry results for Caco2 cell line: (A) control, (B) neat 5-FU and (C) PLGA NPs (0.2)/5-FU, besides for SW-480 cell line: (D) control, (E) neat 5-FU and (F) PLGA NPs (0.2)/5-FU.CC BY · PubMed Central
Figure 8 Representative fluorescence micrographs (DAPI, blue) showing morphologically death of Caco2 and SW-480 cell lines after DAPI staining: (A,D) control [magnification 200×], (B,E) neat 5-FU and (C,F) PLGA NPs (0.2)/5-FU [magnification 400×].
Figure 8 Representative fluorescence micrographs (DAPI, blue) showing morphologically death of Caco2 and SW-480 cell lines after DAPI staining: (A,D) control [magnification 200×], (B,E) neat 5-FU and (C,F) PLGA NPs (0.2)/5-FU [magnification 400×].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Hewitt, 2000, Validation of a model of colon cancer progression, J. Pathol. A J. Pathol. Soc. Gt. Br. Irel., 192, 446

Cited by

See all 39

Metadata

Authors
Ghasemi Toudeshkchouei, M., Zahedi, P., & Shavandi, A.
Affiliations
  • Department of Polymer, School of Chemical Engineering, College of Engineering, University of Tehran, P.O. Box 11155-4563, Tehran 1417613131, Iran
  • University of Tehran (IR)
  • Université Libre de Bruxelles (BE)
Corresponding author
  • Zahedi, Payam
  • Shavandi, Amin
Venue
Materials
Publisher
MDPI AG
Published
2020-03-25
Volume
13
Issue
7
Pages
1483
ISSN
1996-1944 (ISSN-L)
OpenAlex
W3013281133
Cited by
39
References
44
Citations by year
2026: 5 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 2 · 2020: 1
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • Materials (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
Keywords
5-fluorouracil, PLGA nanoparticles, microfluidic fabrication, colorectal cancer, drug delivery, encapsulation efficiency, hydrodynamic focusing, drug release, cytotoxicity, Caco-2 cells, SW480 cells, cell death

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microfluidic-Assisted Preparation of 5-Fluorouracil-Loaded PLGA Nanoparticles as a Potential System for Colorectal Cancer Therapy. https://app.cochat.ai/papers/10.3390/ma13071483
The paper
Ghasemi Toudeshkchouei, M., Zahedi, P., & Shavandi, A. (2020). Microfluidic-Assisted Preparation of 5-Fluorouracil-Loaded PLGA Nanoparticles as a Potential System for Colorectal Cancer Therapy. Materials. https://doi.org/10.3390/ma13071483

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.